tetano
Editor, Senior Moderator
J Cardiothorac Surg
. 2024 Aug 24;19(1):492.
doi: 10.1186/s13019-024-02997-0. Fulminant myocarditis caused by influenza B virus in a male child: a case report and literature review
Fei Tian[SUP] #[/SUP][SUP] 1 2 [/SUP], Yi Xiao[SUP] #[/SUP][SUP] 3 [/SUP], Zhekang Peng[SUP] #[/SUP][SUP] 1 [/SUP], Lingyun Zhang[SUP] 4 [/SUP], Fu Ni[SUP] 5 [/SUP], Shengmin Gui[SUP] 5 2 [/SUP], Yuqing Fan[SUP] 5 [/SUP], Zuyang Xi[SUP] 6 7 [/SUP], Zhaohui Zhang[SUP] 8 [/SUP]
Affiliations
Background: Influenza B virus induced myocarditis is a rare complication with potentially wide variations in severity and clinical presentation, and the pathogenesis is unclear.
Case presentation: We describe a rare case of a 7-year-old boy who developed fulminant myocarditis (FM) due to influenza B virus infection. Treatment measures included mechanical ventilation, vasoactive agents, Extracorporeal membrane oxygenation (ECMO), Continuous Renal Replacement Therapy (CRRT), anti-inflammatory, antiviral, anti-infection, and enteral nutrition support. After 10 days of treatment, the patient succumbed to multiorgan failure.
Conclusions: After a systematic review of the literature, we found that this disease predominantly affects females, with pediatric cases exceedingly rare. Fulminant myocarditis (FM) progresses rapidly, poses significant treatment challenges sporadic, and carries a poor prognosis. Interestingly, literature reports suggest that anti-thymocyte globulin therapy may have a positive impact in treating FM, potentially offering new insights into its pathogenesis and clinical management.
Keywords: Fulminant myocarditis; Influenza B virus; Myocarditis; Viral myocarditis.
. 2024 Aug 24;19(1):492.
doi: 10.1186/s13019-024-02997-0. Fulminant myocarditis caused by influenza B virus in a male child: a case report and literature review
Fei Tian[SUP] #[/SUP][SUP] 1 2 [/SUP], Yi Xiao[SUP] #[/SUP][SUP] 3 [/SUP], Zhekang Peng[SUP] #[/SUP][SUP] 1 [/SUP], Lingyun Zhang[SUP] 4 [/SUP], Fu Ni[SUP] 5 [/SUP], Shengmin Gui[SUP] 5 2 [/SUP], Yuqing Fan[SUP] 5 [/SUP], Zuyang Xi[SUP] 6 7 [/SUP], Zhaohui Zhang[SUP] 8 [/SUP]
Affiliations
- PMID: 39182151
- DOI: 10.1186/s13019-024-02997-0
Background: Influenza B virus induced myocarditis is a rare complication with potentially wide variations in severity and clinical presentation, and the pathogenesis is unclear.
Case presentation: We describe a rare case of a 7-year-old boy who developed fulminant myocarditis (FM) due to influenza B virus infection. Treatment measures included mechanical ventilation, vasoactive agents, Extracorporeal membrane oxygenation (ECMO), Continuous Renal Replacement Therapy (CRRT), anti-inflammatory, antiviral, anti-infection, and enteral nutrition support. After 10 days of treatment, the patient succumbed to multiorgan failure.
Conclusions: After a systematic review of the literature, we found that this disease predominantly affects females, with pediatric cases exceedingly rare. Fulminant myocarditis (FM) progresses rapidly, poses significant treatment challenges sporadic, and carries a poor prognosis. Interestingly, literature reports suggest that anti-thymocyte globulin therapy may have a positive impact in treating FM, potentially offering new insights into its pathogenesis and clinical management.
Keywords: Fulminant myocarditis; Influenza B virus; Myocarditis; Viral myocarditis.